Literature DB >> 16385236

Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan.

Yasuyo Morita1, Takato Ueno, Nozomi Sasaki, Kouichiro Kuhara, Shinichiro Yoshioka, Yukio Tateishi, Eisuke Nagata, Masayoshi Kage, Michio Sata.   

Abstract

BACKGROUND: This study compared the liver histology of patients with NASH and patients with ASH.
METHODS: Subjects consisted of 79 patients (41 in the NASH group and 38 in the ASH group). We performed physical and laboratory examinations as well as liver biopsy in all subjects, and we evaluated the differences between the NASH and ASH groups. In addition, we compared the liver histology of patients with obesity, diabetes or hyperlipidemia within the NASH group. RESULTS AND
CONCLUSIONS: BMI was significantly higher in the NASH group than in the ASH group. Steatosis and nuclear vacuoles were more prevalent in the NASH group than in the ASH group. On the other hand, ballooning hepatocytes, lipogranuloma, focal necrosis, acidophilic bodies and fibrosis were more remarkable in the ASH group than in the NASH group. The degrees of steatosis and lipogranuloma gradually decreased as the stage of liver fibrosis progressed. Necro-inflammation and fibrosis tended to be more remarkable in the ASH group than in the NASH group. In the NASH group, ballooning hepatocytes and acidophilic bodies were significantly higher in the group with diabetes than in that without diabetes. Perivenular fibrosis, pericellular fibrosis and portal fibrosis were also higher in the NASH group with diabetes than in the NASH group without diabetes. These findings suggested that diabetes is deeply involved in the development and progression of NASH.

Entities:  

Mesh:

Year:  2005        PMID: 16385236     DOI: 10.1097/01.alc.0000191777.36629.33

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

1.  Hepatic lipogranulomas in patients with chronic liver disease: association with hepatitis C and fatty liver disease.

Authors:  Hongfa Zhu; Henry C Bodenheimer; David J Clain; Albert D Min; Neil D Theise
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

Review 2.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Authors:  Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Hamasaki; Ryuji Furukawa; Shotarou Tsuruta; Yasuo Ueda; Naota Taura; Hidetaka Shibata; Masumi Fujimoto; Kan Toriyama; Katsumi Eguchi
Journal:  Hepatol Int       Date:  2007-06-01       Impact factor: 6.047

Review 4.  Beverage consumption and paediatric NAFLD.

Authors:  Antonella Mosca; Claudia Della Corte; Maria Rita Sartorelli; Francesca Ferretti; Francesco Nicita; Andrea Vania; Valerio Nobili
Journal:  Eat Weight Disord       Date:  2016-08-26       Impact factor: 4.652

5.  MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice.

Authors:  Angela Dolganiuc; Jan Petrasek; Karen Kodys; Donna Catalano; Pranoti Mandrekar; Arumugam Velayudham; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

Review 6.  Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective.

Authors:  Mohammad Hosein Farzaei; Mahdi Zobeiri; Fatemeh Parvizi; Fardous F El-Senduny; Ilias Marmouzi; Ericsson Coy-Barrera; Rozita Naseri; Seyed Mohammad Nabavi; Roja Rahimi; Mohammad Abdollahi
Journal:  Nutrients       Date:  2018-07-01       Impact factor: 5.717

7.  Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage.

Authors:  Shandiz Morega; Bogdan Cătălin; Cristiana Eugenia Simionescu; Konstantinos Sapalidis; Ion Rogoveanu
Journal:  Brain Sci       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.